Source:http://linkedlifedata.com/resource/pubmed/id/10582612
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
6
|
pubmed:dateCreated |
1999-12-27
|
pubmed:abstractText |
To explore the molecular etiology of two disorders caused by a defect in GTP cyclohydrolase I--hereditary progressive dystonia with marked diurnal fluctuation (HPD), also known as dopa-responsive dystonia (DRD), and autosomal recessive GTP cyclohydrolase I deficiency--we purified and analyzed recombinant human wild-type and mutant GTP cyclohydrolase I proteins expressed in Escherichia coli. Mutant proteins showed very low enzyme activities, and some mutants were eluted at a delayed volume on gel filtration compared with the recombinant wild-type. Next, we examined the GTP cyclohydrolase I protein amount by western blot analysis in phytohemagglutinin-stimulated mononuclear blood cells from HPD/DRD patients. We found a great reduction in the amount of the enzyme protein not only in one patient who had a frameshift mutation, but also in an HPD/DRD patient who had a missense mutation. These results suggest that a dominant-negative effect of chimeric protein composed of wild-type and mutant subunits is unlikely as a cause of the reduced enzyme activity in HPD/DRD patients. We suggest that reduction of the amount of the enzyme protein, which is independent of the mutation type, could be a reason for the dominant inheritance in HPD/DRD.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/5,6,7,8-tetrahydrobiopterin,
http://linkedlifedata.com/resource/pubmed/chemical/Biopterin,
http://linkedlifedata.com/resource/pubmed/chemical/GTP Cyclohydrolase,
http://linkedlifedata.com/resource/pubmed/chemical/Phenylalanine,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Fusion Proteins
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0022-3042
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
73
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
2510-6
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10582612-Amino Acid Sequence,
pubmed-meshheading:10582612-Biopterin,
pubmed-meshheading:10582612-DNA Mutational Analysis,
pubmed-meshheading:10582612-Dystonic Disorders,
pubmed-meshheading:10582612-Frameshift Mutation,
pubmed-meshheading:10582612-GTP Cyclohydrolase,
pubmed-meshheading:10582612-Gene Expression Regulation,
pubmed-meshheading:10582612-Genes, Dominant,
pubmed-meshheading:10582612-Genes, Recessive,
pubmed-meshheading:10582612-Humans,
pubmed-meshheading:10582612-Molecular Sequence Data,
pubmed-meshheading:10582612-Neuroblastoma,
pubmed-meshheading:10582612-Phenylalanine,
pubmed-meshheading:10582612-Point Mutation,
pubmed-meshheading:10582612-Recombinant Fusion Proteins,
pubmed-meshheading:10582612-Tumor Cells, Cultured
|
pubmed:year |
1999
|
pubmed:articleTitle |
Characterization of wild-type and mutants of recombinant human GTP cyclohydrolase I: relationship to etiology of dopa-responsive dystonia.
|
pubmed:affiliation |
Division of Molecular Genetics, Institute for Comprehensive Medical Science, Fujita Health University, Aichi, Japan.
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, Non-U.S. Gov't
|